Integrity Score 4442
No Records Found
No Records Found
No Records Found
Cardiovascular risks and COVID-19: New research confirms the benefits of vaccination
By Glen Pyle, University of Guelph
COVID-19 is a respiratory disease. Yet, from the earliest days of the pandemic, the cardiovascular risks associated with SARS-CoV-2 infection were clear: individuals with severe cases of COVID-19 often died from cardiovascular complications, and those with pre-existing cardiovascular disease were more likely to have severe illness or die.
In short, the cardiovascular system has played a central role in COVID-19 since the beginning.
It is not surprising that as debate over COVID-19 and vaccines flared that cardiovascular disease was a central issue. Those opposed to vaccination often make claims of cardiovascular risks that exceed any benefits. But when data on COVID-19, vaccines and cardiovascular health are reviewed, the conclusions are clear: vaccines are safe and effective at reducing the cardiovascular complications that are a hallmark of COVID-19.
Hot off the presses
A new study of 20.5 million people in the United Kingdom, Spain and Estonia used electronic health records to determine how COVID-19 vaccines affect cardiovascular complications following SARS-CoV-2 infection. Roughly the same number of vaccinated and unvaccinated subjects were included, and the vaccinated group consisted of people who received at least one of the AstraZeneca, Pfizer, Moderna or Janssen vaccines.
The study found that common cardiovascular complications of COVID-19 — including blood clots, stroke, arrhythmias and heart attacks — were substantially reduced in the vaccinated group, with protective effects lasting up to a year after vaccination.
Bigger picture
While this most recent study represents one of the most comprehensive investigations into the cardiovascular benefits of COVID-19 vaccination, its findings are consistent with earlier, smaller studies.
A 2022 study of 231,037 people found two doses of COVID-19 vaccines reduced the risk of stroke and heart attack up to four months after a breakthrough infection.
A subsequent study of 1.9 million people found that while two doses of the mRNA vaccines or one dose of the Johnson & Johnson vaccine protected against major cardiovascular events following COVID-19, even a single dose of the mRNA vaccines offered some benefit in reducing the risk of cardiovascular complications.
Read Full Story https://theconversation.com/cardiovascular-risks-and-covid-19-new-research-confirms-the-benefits-of-vaccination-226130